- Home
- ALTO vs XBIT Comparison
ALTO vs XBIT Comparison
Compare ALTO & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALTO | XBIT |
|---|---|---|
| Founded | 2003 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Pharmaceuticals and Biotechnology |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.1M | 69.5M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | ALTO | XBIT |
|---|---|---|
| Price | $2.54 | $2.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.50 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 73.6K |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $922,309,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.76 | $2.09 |
| 52 Week High | $2.92 | $7.24 |
Technical Indicators
Market Signals| Indicator | ALTO | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 62.94 | 48.15 |
| Support Level | $2.28 | $2.15 |
| Resistance Level | $2.64 | $2.65 |
| Average True Range (ATR) | 0.25 | 0.15 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 54.17 | 33.33 |
Price Performance
Historical ComparisonAbout ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under four segments: Marketing and distribution, Pekin Campus production, Western production, and Corporate.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.